Abacavir, dolutegravir, and lamivudine and Tapentadol Extended-Release Tablets
Determining the interaction of Abacavir, dolutegravir, and lamivudine and Tapentadol Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: abacavir / dolutegravir / lamivudine
Brand name: Triumeq
Synonyms: Abacavir, Dolutegravir, and Lamivudine
Generic Name: tapentadol
Brand name: Nucynta, Nucynta ER
Synonyms: Tapentadol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abacavir, dolutegravir, and lamivudine-Tapentadol Hydrochloride
- Abacavir, dolutegravir, and lamivudine-Tapentadol Tablets
- Abacavir, dolutegravir, and lamivudine-TaperDex 12-day
- Abacavir, dolutegravir, and lamivudine-TaperDex 6-day
- Abacavir, dolutegravir, and lamivudine-TaperDex 7-day
- Abacavir, dolutegravir, and lamivudine-Tar Distillate Topical
- Tapentadol Extended-Release Tablets-Abacavir, Lamivudine and Zidovudine Tablets
- Tapentadol Extended-Release Tablets-Abacavir, lamivudine, and zidovudine
- Tapentadol Extended-Release Tablets-Abaloparatide
- Tapentadol Extended-Release Tablets-Abaloparatide Subcutaneous
- Tapentadol Extended-Release Tablets-Abatacept
- Tapentadol Extended-Release Tablets-Abatacept Auto-Injectors